Medical device industry regulation is changing: What you need to know

The medical device industry has been taking a lot of heat lately when it comes to patient safety.

There’s the recent International Consortium of Investigative Journalists’ “Implant Files” report, as well as the documentary “Bleeding Edge” on Netflix. Both paint a picture of lax medical device regulation resulting in patients exposed to poorly tested implants.

Veteran regulatory consultant Michael Drues thinks the problems outlined in the reports echo concerns going all the way back to when the FDA started regulating medical devices in 1976.

They raise similar questions, too. “What do we do to prevent them? How do we prevent more from happening?” Drues said during his newest podcast with Medical Design & Outsourcing.

Drues is skeptical whether some of the changes proposed at FDA will work, including a proposal to move away from using predicate devices more than 10 years old in the 510(k) clearance process. No matter what, Drues has noticed agency regulators interpreting regulations differently than in the past, especially when it comes to 510(k) clearances.

“Just over the last one or two months, I’ve had a few devices that we’ve brought to the FDA with strong cases to bring to the market as a 510(k) – FDA has been pushing hard to do a de novo instead,” Drues said.

Listen to the full podcast with Drues:

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW